Funding
← Back to your selection

Elikon Venture

Activity from announced rounds

Activity in this selectionJan 31, 2026 · Jan 1, 2026
Rounds participated in
2
Confirmed lead rounds
—
2 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$83M
2 disclosed · full round size, not this investor’s share

By stage

Seed1
Series C+1

By primary sector

Biotech2

By country

China1
United States1

Rounds

2 in this selection
Oricell Therapeutics

Develops next-generation cell therapies for oncology and immunology

$70MSeries C1
Role not disclosed